Clinical Trials Logo

Periorbital Disorder clinical trials

View clinical trials related to Periorbital Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04745078 Completed - Clinical trials for Periorbital Disorder

Carboxytherapy for Periorbital Dark Circles

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

the study evaluates carboxytherapy for the treatment of periorbital dark circles

NCT ID: NCT03393624 Completed - Clinical trials for Periorbital Disorder

Influence of Sleep Quality in Patients With Periorbicular Hyperchromia

Start date: October 1, 2017
Phase:
Study type: Observational

Periorbital hyperchromia (POH) or periorbital hyperpigmentation, commonly known as "dark circles", is a relatively common condition and a frequent reason for dermatological consultation. It is defined as brown-colored pigmentation, ranging from light to dark, which mainly involves the lower eyelids. POH affects individuals over a wide age range, including both sexes and all ethnicities, and is associated with a tired and aged facial appearance. The most commonly affected people are those with the highest skin phototypes. Although the prevalence is similar between sexes and age groups, POH is a more frequent complaint in women. The dark circles characteristic of POH can negatively impact patients' quality of life, although it is not a condition associated with morbidity. Popularly it is believed that the poor quality of sleep is a factor responsible for its appearance, but there is no consistent data in the literature that prove this.